» Articles » PMID: 38809279

The Radiomorphological Appearance of the Invasive Margin in Pancreatic Cancer is Associated with Tumor Budding

Overview
Specialty General Surgery
Date 2024 May 29
PMID 38809279
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Pancreatic cancer (PDAC) is characterized by infiltrative, spiculated tumor growth into the surrounding non-neoplastic tissue. Clinically, its diagnosis is often established by magnetic resonance imaging (MRI). At the invasive margin, tumor buds can be detected by histology, an established marker associated with poor prognosis in different types of tumors.

Methods: We analyzed PDAC by determining the degree of tumor spiculation on T2-weighted MRI using a 3-tier grading system. The grade of spiculation was correlated with the density of tumor buds quantified in histological sections of the respective surgical specimen according to the guidelines of the International Tumor Budding Consensus Conference (n = 28 patients).

Results: 64% of tumors revealed intermediate to high spiculation on MRI. In over 90% of cases, tumor buds were detected. We observed a significant positive rank correlation between the grade of radiological tumor spiculation and the histopathological number of tumor buds (r = 0.745, p < 0.001). The number of tumor buds was not significantly associated with tumor stage, presence of lymph node metastases, or histopathological grading (p ≥ 0.352).

Conclusion: Our study identifies a readily available radiological marker for non-invasive estimation of tumor budding, as a correlate for infiltrative tumor growth. This finding could help to identify PDAC patients who might benefit from more extensive peripancreatic soft tissue resection during surgery or stratify patients for personalized therapy concepts.

References
1.
Mayer P, Dinkic C, Jesenofsky R, Klauss M, Schirmacher P, Dapunt U . Changes in the microarchitecture of the pancreatic cancer stroma are linked to neutrophil-dependent reprogramming of stellate cells and reflected by diffusion-weighted magnetic resonance imaging. Theranostics. 2018; 8(1):13-30. PMC: 5743457. DOI: 10.7150/thno.21089. View

2.
Karamitopoulou E, Zlobec I, Born D, Kondi-Pafiti A, Lykoudis P, Mellou A . Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Eur J Cancer. 2012; 49(5):1032-9. DOI: 10.1016/j.ejca.2012.10.022. View

3.
Jha P, Yeh B, Zagoria R, Collisson E, Wang Z . The Role of MR Imaging in Pancreatic Cancer. Magn Reson Imaging Clin N Am. 2018; 26(3):363-373. DOI: 10.1016/j.mric.2018.03.004. View

4.
Kim J, Altun E, Elias Jr J, Pamuklar E, Rivero H, Semelka R . Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging. 2007; 26(2):313-22. DOI: 10.1002/jmri.21010. View

5.
Guo J, Li J, Zhao Y, Zhou L, Cui Q, Zhou W . N-wasp in pancreatic ductal adenocarcinoma: associations with perineural invasion and poor prognosis. World J Surg. 2014; 38(8):2126-31. DOI: 10.1007/s00268-014-2500-8. View